APA (7th ed.) Citation

Li, S., Hao, L., Hu, X., & Li, L. (2023). A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification. BMC.

Chicago Style (17th ed.) Citation

Li, Shenghao, Liyuan Hao, Xiaoyu Hu, and Luya Li. A Systematic Study on the Treatment of Hepatitis B-related Hepatocellular Carcinoma with Drugs Based on Bioinformatics and Key Target Reverse Network Pharmacology and Experimental Verification. BMC, 2023.

MLA (9th ed.) Citation

Li, Shenghao, et al. A Systematic Study on the Treatment of Hepatitis B-related Hepatocellular Carcinoma with Drugs Based on Bioinformatics and Key Target Reverse Network Pharmacology and Experimental Verification. BMC, 2023.